• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒与复发性呼吸道乳头状瘤病:简要综述

HPV and Recurrent Respiratory Papillomatosis: A Brief Review.

作者信息

Ouda Amr Mohamed, Elsabagh Ahmed Adel, Elmakaty Ibrahim Mohamed, Gupta Ishita, Vranic Semir, Al-Thawadi Hamda, Al Moustafa Ala-Eddin

机构信息

College of Medicine, QU Health, Qatar University, Doha 2713, Qatar.

Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha 2713, Qatar.

出版信息

Life (Basel). 2021 Nov 22;11(11):1279. doi: 10.3390/life11111279.

DOI:10.3390/life11111279
PMID:34833157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8618609/
Abstract

Recurrent Respiratory Papillomatosis (RRP) is a rare but severe manifestation of human papillomavirus (HPV). As our knowledge about HPV infections has expanded, it has become possible to understand the course of RRP disease and unravel plausible efficient methods to manage the disease. However, the surge in reports on HPV has not been accompanied by a similar increase in research about RRP specifically. In this paper, we review the clinical manifestation and typical presentation of the illness. In addition, the pathogenesis and progression of the disease are described. On the other hand, we discuss the types of treatments currently available and future treatment strategies. The role of vaccination in both the prevention and treatment of RRP will also be reviewed. We believe this review is essential to update the general knowledge on RRP with the latest information available to date to enhance our understanding of RRP and its management.

摘要

复发性呼吸道乳头状瘤病(RRP)是一种由人乳头瘤病毒(HPV)引起的罕见但严重的病症。随着我们对HPV感染的了解不断深入,已能够理解RRP疾病的病程,并找到合理有效的治疗方法。然而,HPV报告数量的激增并未伴随针对RRP的研究有类似增长。在本文中,我们回顾了该疾病的临床表现和典型症状。此外,还描述了疾病的发病机制和进展。另一方面,我们讨论了目前可用的治疗类型和未来的治疗策略。还将回顾疫苗接种在RRP预防和治疗中的作用。我们认为,本次综述对于用最新信息更新RRP的一般知识至关重要,有助于加深我们对RRP及其管理的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf4/8618609/2bf56b9ca320/life-11-01279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf4/8618609/2bf56b9ca320/life-11-01279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf4/8618609/2bf56b9ca320/life-11-01279-g001.jpg

相似文献

1
HPV and Recurrent Respiratory Papillomatosis: A Brief Review.人乳头瘤病毒与复发性呼吸道乳头状瘤病:简要综述
Life (Basel). 2021 Nov 22;11(11):1279. doi: 10.3390/life11111279.
2
Current and future management of recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病的当前及未来管理
Laryngoscope Investig Otolaryngol. 2018 Jan 14;3(1):22-34. doi: 10.1002/lio2.132. eCollection 2018 Feb.
3
Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.复发性呼吸道乳头瘤病患者接种人乳头瘤病毒疫苗的结局:一项非随机临床试验。
JAMA Otolaryngol Head Neck Surg. 2022 Jul 1;148(7):654-661. doi: 10.1001/jamaoto.2022.1190.
4
Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.成人复发性呼吸道乳头状瘤病:疾病发病机制综述及对患者咨询的意义
JAMA Otolaryngol Head Neck Surg. 2015 Jan;141(1):78-83. doi: 10.1001/jamaoto.2014.2826.
5
Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病患者的人乳头瘤病毒基因分型与严重程度
J Med Assoc Thai. 2014 Jun;97 Suppl 6:S136-41.
6
Recurrent respiratory papillomatosis: A 2020 perspective.复发性呼吸道乳头状瘤病:2020年视角
Laryngoscope Investig Otolaryngol. 2021 Mar 13;6(2):340-345. doi: 10.1002/lio2.545. eCollection 2021 Apr.
7
Human Papillomavirus Vaccination as an Adjuvant Therapy for Recurrent Respiratory Papillomatosis: Additional Case Series.人乳头瘤病毒疫苗作为复发性呼吸道乳头瘤病的辅助治疗:附加病例系列。
J Voice. 2024 Jan;38(1):204-209. doi: 10.1016/j.jvoice.2021.07.019. Epub 2021 Sep 30.
8
Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.常规人乳头瘤病毒疫苗接种在复发性呼吸道乳头状瘤病管理中的应用
Ann Otol Rhinol Laryngol. 2019 Apr;128(4):309-315. doi: 10.1177/0003489418821695. Epub 2018 Dec 29.
9
Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.HPV 疫苗接种致复发性呼吸道乳头瘤病自发消退:1 例病例研究。
J Voice. 2022 Jul;36(4):587.e21-587.e25. doi: 10.1016/j.jvoice.2020.08.013. Epub 2020 Sep 3.
10
Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.在津巴布韦导致复发性呼吸道乳头状瘤病的人乳头瘤病毒类型。
Int J Pediatr Otorhinolaryngol. 2019 Jan;116:147-152. doi: 10.1016/j.ijporl.2018.10.036. Epub 2018 Oct 26.

引用本文的文献

1
Impact of the HPV Vaccine on Oral HPV Infections in Indigenous Australian Adults.人乳头瘤病毒疫苗对澳大利亚原住民成年人口腔人乳头瘤病毒感染的影响。
Vaccines (Basel). 2025 Jun 26;13(7):685. doi: 10.3390/vaccines13070685.
2
Lung cancer in young individuals; risk factors and epidemiology.年轻个体中的肺癌;危险因素与流行病学
J Thorac Dis. 2025 Mar 31;17(3):1746-1754. doi: 10.21037/jtd-2024-1950. Epub 2025 Mar 21.
3
HPV and Cervical Cancer-Biology, Prevention, and Treatment Updates.人乳头瘤病毒与宫颈癌——生物学、预防及治疗进展

本文引用的文献

1
An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病相关流行病学因素的最新综述。
Laryngoscope Investig Otolaryngol. 2021 Jan 28;6(2):226-233. doi: 10.1002/lio2.521. eCollection 2021 Apr.
2
Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland.儿童在生命的头 6 年中发生的口腔人乳头瘤病毒感染,芬兰。
Emerg Infect Dis. 2021 Mar;27(3):759-766. doi: 10.3201/eid2703.202721. Epub 2021 Jan 29.
3
Juvenile-Onset Recurrent Respiratory Papillomatosis Aggressiveness: In Situ Study of the Level of Transcription of HPV E6 and E7.
Curr Oncol. 2025 Feb 22;32(3):122. doi: 10.3390/curroncol32030122.
4
Recurrent respiratory papillomatosis: role of bevacizumab and HPV vaccination. A literature review with case presentations.复发性呼吸道乳头状瘤病:贝伐单抗和人乳头瘤病毒疫苗接种的作用。附病例报告的文献综述。
Radiol Oncol. 2025 Feb 27;59(1):23-30. doi: 10.2478/raon-2025-0010. eCollection 2025 Mar 1.
5
DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107.用于复发性呼吸道乳头状瘤病(RRP)的DNA免疫疗法:评估INO-3107疗效、安全性和免疫原性的1/2期研究
Nat Commun. 2025 Feb 12;16(1):1518. doi: 10.1038/s41467-025-56729-6.
6
Emergency Debulking of Recurrent Respiratory Papillomatosis: An Anesthesia Challenge.复发性呼吸道乳头状瘤病的急诊减瘤手术:一项麻醉挑战
Cureus. 2024 Nov 25;16(11):e74404. doi: 10.7759/cureus.74404. eCollection 2024 Nov.
7
HPV and Lung Cancer: A Systematic Review.人乳头瘤病毒与肺癌:一项系统综述
Cancers (Basel). 2024 Sep 28;16(19):3325. doi: 10.3390/cancers16193325.
8
Successful Bevacizumab Therapy in a 25-Year-Old Patient with Recurrent Respiratory Papillomatosis.贝伐单抗成功治疗一名25岁复发性呼吸道乳头状瘤病患者。
Eur J Case Rep Intern Med. 2024 Sep 6;11(10):004840. doi: 10.12890/2024_004840. eCollection 2024.
9
Unveiling the multifaceted realm of human papillomavirus: a comprehensive exploration of biology, interactions, and advances in cancer management.揭示人类乳头瘤病毒的多面领域:对生物学、相互作用以及癌症管理进展的全面探索。
Front Immunol. 2024 Aug 8;15:1430544. doi: 10.3389/fimmu.2024.1430544. eCollection 2024.
10
VEGF as a Key Actor in Recurrent Respiratory Papillomatosis: A Narrative Review.血管内皮生长因子作为复发性呼吸道乳头状瘤病的关键因素:一篇叙述性综述
Curr Issues Mol Biol. 2024 Jul 1;46(7):6757-6768. doi: 10.3390/cimb46070403.
青少年期复发性呼吸道乳头状瘤的侵袭性:人乳头瘤病毒E6和E7转录水平的原位研究
Cancers (Basel). 2020 Oct 1;12(10):2836. doi: 10.3390/cancers12102836.
4
Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP).复发性呼吸道乳头瘤病(RRP)患者的单核细胞和朗格汉斯细胞固有免疫改变。
Front Immunol. 2020 Mar 10;11:336. doi: 10.3389/fimmu.2020.00336. eCollection 2020.
5
Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management - A Developing Country Review.青少年复发性呼吸道乳头状瘤病的诊断与管理——发展中国家综述
Pediatric Health Med Ther. 2020 Feb 4;11:39-46. doi: 10.2147/PHMT.S200186. eCollection 2020.
6
Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.靶向人乳头瘤病毒6型(HPV-6)E6/E7癌基因的免疫疗法减少或消除了治疗HPV-6相关复发性呼吸道乳头状瘤病时手术干预的必要性。
Vaccines (Basel). 2020 Jan 29;8(1):56. doi: 10.3390/vaccines8010056.
7
International Pediatric Otolaryngology Group (IPOG): Juvenile-onset recurrent respiratory papillomatosis consensus recommendations.国际儿科耳鼻咽喉科小组(IPOG):青少年复发性呼吸道乳头状瘤病共识建议
Int J Pediatr Otorhinolaryngol. 2020 Jan;128:109697. doi: 10.1016/j.ijporl.2019.109697. Epub 2019 Sep 28.
8
Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.复发性呼吸道乳头瘤病中低危型 HPV 的免疫耐受。
Clin Exp Immunol. 2020 Feb;199(2):131-142. doi: 10.1111/cei.13387. Epub 2019 Oct 31.
9
Human papillomavirus and cervical cancer.人乳头瘤病毒与宫颈癌。
J Obstet Gynaecol. 2020 Jul;40(5):602-608. doi: 10.1080/01443615.2019.1634030. Epub 2019 Sep 10.
10
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System.乳头瘤病毒免疫逃逸策略针对受感染细胞和局部免疫系统。
Front Oncol. 2019 Aug 2;9:682. doi: 10.3389/fonc.2019.00682. eCollection 2019.